GPP
LKFT

Great Point Partners’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Great Point Partners’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-306,411
Closed -$13.1M – 46
2022
Q3 		$13.1M Sell
306,411
-53,589
-15% -$2.75M 3.15% 12
2022
Q2 		$20.1M Hold
360,000
– – 5.18% 7
2022
Q1 		$22.3M Buy
360,000
+60,000
+20% +$3.67M 5.4% 8
2021
Q4 		$16.5M Buy
+300,000
New +$15.7M 3.7% 8

Other funds holding LKFT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $417M AUM 45.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return